SCHEMBL7992337

SCHEMBL7992337

CCc1nc(O)c2c(ncn2Cc2cc(C(C)(C)C)c(OCc3ccccc3)c(C(C)(C)C)c2)n1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.35
HPGD P15428 3/20 0.34
SMN1; SMN2 Q16637 4/20 0.33
ALDH1A1 P00352 3/20 0.33
TSHR P16473 1/20 0.33
KMT2A Q03164 2/20 0.32
HTT P42858 2/20 0.32
MEN1 O00255 1/20 0.32
RXRA P19793 1/20 0.32
RXRB P28702 1/20 0.32
RXRG P48443 1/20 0.32
TLR7 Q9NYK1 1/20 0.32
FEN1 P39748 1/20 0.32
DAPK1 P53355 1/20 0.32
MAPK14 Q16539 1/20 0.31
LMNA P02545 1/20 0.31
NR1I2 O75469 1/20 0.31
ALOX5AP P20292 1/20 0.31
NPC1 O15118 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987443 0.87 GAA (0.37) GAAHPGDSMN1; SMN2ALDH1A1TSHR
SCHEMBL7985521 0.83 ALDH1A1 (0.41) GAAHPGDSMN1; SMN2ALDH1A1TSHR
SCHEMBL7975252 0.82 HPGD (0.45) GAAHPGDSMN1; SMN2ALDH1A1TSHR
SCHEMBL7987782 0.82 NPC1 (0.44) GAAHPGDSMN1; SMN2ALDH1A1TSHR
SCHEMBL7992335 0.79 HPGD (0.44) GAAHPGDSMN1; SMN2ALDH1A1KMT2A
SCHEMBL7973934 0.76 CYP11B1 (0.45) GAAHPGDSMN1; SMN2ALDH1A1KMT2A
SCHEMBL7984468 0.76 ABCC8 (0.46) HPGDSMN1; SMN2ALDH1A1LMNANR1I2
SCHEMBL7985471 0.76 HPGD (0.43) GAAHPGDSMN1; SMN2ALDH1A1TSHR
SCHEMBL7984378 0.75 CYP11B1 (0.42) GAAHPGDSMN1; SMN2ALDH1A1TLR7
SCHEMBL7988129 0.75 MET (0.44) GAAHPGDSMN1; SMN2ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed